To develop new functional foods for the prevention of atherosclerosis, we evaluated the cholesterollowering effects of several strains of Lactobacillus (L.) brevis. These strains included the γ-amino butyric acid-producing strains L. brevis 119-2 and L. brevis 119-6, isolated from turnip "tsuda kabu" and pickled turnip "tsuda kabu zuke", respectively. To evaluate the cholesterol-lowering effects of L. brevis in vitro and to examine potential mechanisms of this property, we evaluated changes in levels of cholesterol, sodium taurocholate, and cholic acid in growth medium containing cholesterol and sodium taurocholate. Moreover, to assess the potential of L. brevis 119-2 and L. brevis 119-6 for probiotic use, we examined the tolerance of L. brevis to artificial digestive fluid and its adherence to epithelial cells. Our results indicate that L. brevis 119-2 incorporates cholesterol from the medium into the cell, and that L. brevis 119-2 and L. brevis 119-6 are probiotic bacteria. Therefore, we propose that viable cells of L. brevis 119-2 can reach the small intestine, where they can inhibit intestinal absorption of cholesterol in vivo by incorporation of cholesterol into the cell.
Introduction
Serum cholesterol levels are correlated with the risk of developing atherosclerosis, which is a factor in ischemic heart disease and other lethal diseases. Manson et al. (1992) noted that in humans a 1% decrease in serum cholesterol levels reduced the risk of atherosclerosis by 2 − 3%. Dyslipidemia (including hypercholesterolemia), hypertension, and hyperglycemia are all risk factors for the development of atherosclerosis. Metabolic syndrome combined with at least two other factors (hyperlipidemia, hypertension, or hyperglycemia) led to visceral fat-type obesity, synergistically increasing the risk of atherosclerosis (Kaplan, 1989) .
In contrast to these recent developments, lactic acid bacteria (LAB) have been incorporated into fermented foods such as sake, cheese, and pickles since ancient times. Recently, probiotic functions have been reported for LAB, including immune stimulating activity (Kimura et al., 2006) , suppression of intestinal growth of pathogenic bacteria (Gagnon, 2004; Ostad et al., 2009) , and cholesterol-lowering effects (Noh et al., 1997) . We isolated LAB producing γ-amino butyric acid (GABA), a compound known to suppress elevated blood pressure associated with atherosclerosis, from red turnip (tsuda kabu) and traditional fermented pickled turnip (tsuda kabu zuke) (Inoue et al., 2003) . We identified these GABA-producing LAB as L. brevis strains, and designated them as L. brevis 119-2 and L. brevis 119-6, respectively. L. brevis is a plant-associated LAB reported to exhibit probiotic functions, for example, GABA production (Yokoyama et al., 2002) , hepatic disease prevention (Segawa et al., 2008b) , and immune activity (Segawa et al., 2008a) . In this context, L. brevis is an important species for the functional food industry. In the present study, we investigated potential features of our L. brevis strains that might contribute to the prevention of heart disease, including GABA anti-hypertensive effects and cholesterol-lowering effects. To determine the mechanisms of the observed cholesterol-lowering effects, we evaluated the potential roles of deconjugation of bile acid, cholesterol binding to dead cells, and cholesterol metabolism. We also assayed our L. brevis isolates for tolerance to simulated gastric fluids and adherence to epithelial cells, properties typically associated with probiotics. Our results demonstrate that L. brevis 119-2 may be a cholesterol-lowering probiotic.
for 1 min, according to the manufacturer's instructions. DNA sequences of the resulting fragments were determined using a LIC-4200L(s) sequencer (Aloka Co. Ltd, Tokyo, Japan), with homology searches performed against the DNA Data Bank of Japan (DDBJ). Phenotypic identification of species were achieved by using the API Bacterial Identification kit (bioMérieux, NC, USA).
Cholesterol-lowering effects of L. brevis The cholesterol-lowering assay was modified from the method of Kimoto et al. (2002) . Specifically, bacterial cell cultures were harvested, washed with sterile saline, and resuspended in sterile saline to a cell density sufficient to yield an optical density of 0.15 at 650 nm (OD 650 ) for a 10-fold diluted bacterial suspension. The bacterial suspension (undiluted) was inoculated at 1:100 into MRS-THIO (MRS broth containing 0.2% sodium thioglycollate) supplemented with 0.2% sodium taurocholate. Sterilized cholesterol solution (10 mg/mL in ethanol) was then added to the broth to a final concentration of 70 μg/ mL. LAB were incubated at 37℃ for 20 h with shaking at 50 rpm under anaerobic conditions (Gas Pack System BBL; Becton, Dickinson, and Company), and the supernatant and cells were collected by centrifugation at 2,800 × g at 4℃ for 10 min. The cells were resuspended in the same volume of distilled water. A 200 μL aliquot of the supernatant medium or cell suspension was added to 600 μL of 33% KOH and 3.0 mL EtOH, and then incubated in a hot water bath at 60℃ for 30 min to saponify. Cold hexane (5.0 mL) and 3.0 mL of water were added to the saponified solution and shaken. The precipitate in the incubation flask or centrifuge tube was collected using cold hexane. After hexane was distilled out of the organic phase in vacuo, cholesterol was reacted with sulfuric acid and 0.2% o-phthalaldehyde (OPA) and quantified by measuring the absorbance at 550 nm. The cholesterol concentration in the culture medium was normalized using a calibration curve. Samples with low cholesterol concentrations (< 2.5 μg/mL) were assessed by gas chromatography/mass spectrometry (GC/MS; GCQ Thermo Fisher Scientific, MA, USA), for which He gas served as the eluent, the flow rate was 1.2 mL/min, and the mode was split-less. 5α-cholestan was used as the internal standard.
Cholesterol-lowering effects of heated bacteria The cholesterol reduction assay using heated bacteria followed the method of Kimoto et al. (2002) , with modification. L. brevis 119-2, L. brevis 119-6, L. brevis NBRC3960, L. brevis NBRC13109, L. plantarum NRIC1918, and L. acidophilus ATCC43121 were harvested after preculture, washed three times with sterile water, and resuspended as indicated above (to OD 650 of 0.15 at 1:10). The suspension was diluted to 1:100 in fresh MRS broth and then incubated at 37℃ for 20 h with shaking at 50 rpm. The cells were harvested and
Methods
Strains and culture L. brevis strains 119-2 and 119-6 were obtained from our laboratory stock cultures. L. brevis strains NBRC12005, NBRC3345, NBRC3960, NBRC12520, NBRC13109, and NBRC13110, along with Lactococcus (Lc.) lactis NBRC12007, were purchased from the National Institute of Technology and Evaluation (NITE). L. plantarum NRIC1918, L. rhamnosus GG ATCC53103, and L. acidophilus ATCC43121 were purchased from the NODAI culture collection center (Tokyo University of Agriculture, Tokyo) and American Type Culture Collection (VA, USA) supplied by Summit Pharmaceuticals International Corporation, respectively. Except as noted, the strains were cultured in MRS broth medium (Becton, Dickinson and Company, MD, USA) at 37℃ for 24 h, with shaking at 50 rpm. Preculture was repeated three times. Caco-2 cells, obtained from Riken Bioresource Center (Tsukuba, Japan), were used as a cell line designated ECA8601202. The cells were maintained at 37℃ in 5% (v/v) CO 2 in Dulbecco's modified Eagle medium (DMEM; Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 20% (v/v) heat-inactivated fetal bovine serum, 1% non-essential amino acids, 100 U/mL penicillin, and 100 μg/mL streptomycin. Spent medium was replaced every 2 days. The cells were plated onto 60-mm dishes (Falcon; Becton, Dickinson and Company) at approximately 1.4 × 10 4 cells/cm 2 and grown to total confluence with high differentiation (dome formation).
Isolation and identification of GABA-producing microorganisms To obtain GABA-producing lactic acid bacteria (LAB), we isolated LAB from several traditional fermented foods, including pickled turnip (Brassica rapa) "tsuda kabu zuke," pickled wasabi "wasabi ha zuke," and pickled fish (Plecoglossus altivelis) "uruka" and "nigauruka." LAB were also isolated from the leaves of several plants, including mulberry (Morus alba), mallotus bark (Mallotus japonicus), wasabi (Wasabia japonica), and turnip (Brassica rapa) tsuda kabu. For each source, material was homogenized at 1:10 (w:v) in saline, and the homogenates were spread onto MRS agar plates containing 5% precipitated calcium carbonate. LAB colonies with halos were picked after incubation for 2 days at 37℃. Selected colonies were incubated in medium containing 1% sodium glutamate, and GABA was detected in the growth medium using an amino acid analyzer (D-6000, Hitachi Ltd., Tokyo, Japan) after incubation for 2 days at 37℃. Isolated GABA-producing LAB were identified using 16S rDNA sequence analysis using commercial kits. Polymerase chain reaction (PCR) was performed using the primers 5′-AAATTTCCGGG-3′ and 5′-TTTGGGCCCAAA-3′ and Takara Ex Taq kit (Takara Bio Inc., Shiga, Japan) with the following conditions: 30 cycles of 98℃ for 10 sec, 68℃ cultured in MRS broth at 37℃ for 24 h, with shaking, for a total of three times. To simulate stomach conditions, the harvested cells were resuspended in artificial gastric juice [MRS broth containing 0.32% pepsin (110 units/100 mL) with pH adjusted to 3.0, 2.5, or 2.0]. The cells were incubated at 37℃ for 4 h in artificial gastric juice, and serial dilutions were plated to determine viable cell numbers. To simulate intestinal conditions, the harvested cells were resuspended in artificial bile solution (MRS broth containing 0.13, 0.25, 0.5, or 1.0 % Oxgall; Becton, Dickinson and Company). Increases in optical density at 650 nm during the 16 h incubation were used to compare growth of the cultures.
Adhesion of L. brevis to epithelial cells L. brevis adhesion to Caco-2 cells was assayed using the modified method of Lee et al. (2000) . The Caco-2 cells were seeded into 6-well tissue culture dishes at a cell density of 1.25 × 10 5 / mL and grown until 15 days after achieving confluence. The bacterial strains (suspended at 1.5 × 10 8 / mL) were diluted 100-fold with antibiotic-free DMEM. An aliquot (3 mL) of the suspension was added to each well of the 6-well tissue culture dishes. After incubation at 37℃ for 60 min under a 5% CO 2 atmosphere, the Caco-2 cells were washed twice with 0.25% trypsin-PBS, and the number of Caco-2 cells was counted. The bacterial cells of the suspension were harvested by centrifugation at 200 × g for 10 min at room temperature, resuspended in saline for serial dilution, and inoculated in MRS containing 1% agar and 3% precipitated calcium carbonate at 37℃ for 48 h. The number of LAB colonies was counted and calculated as colony forming units (cfu) per Caco-2 cell. To observe LAB adherence to Caco-2 cells, a culture slide (Becton, Dickinson and Company) was used as the growth plate. After incubation, LAB and Caco-2 cells on the culture slide were washed with PBS, fixed with methanol, Gram stained, and observed microscopically. L. rhamnosus GG ATCC53103 and Lc. lactis were used as positive and negative controls, respectively. Statistical analysis Statistical analyses were performed using SPSS v.19 software (IBM). P values < 0.05 were considered to be statistically significant. Between group comparisons were performed using the Student's t-test. Multiple comparisons were performed using ANOVA with Tukey's HSD post-hoc test where significance was indicated.
Results
Cholesterol-lowering effects of L. brevis The cholesterol-lowering effects of eight strains of L. brevis (including strains 119-2 and 119-6) along with L. plantarum NRIC1918 and L. rhamnosus GG ATCC53103 (Table 1) were assessed in vitro. The effect of L. acidophilus ATCC43121 on cholesterol removal has been reported previously (Nguyen et al., autoclaved at 120℃ for 20 min. The harvested cells were resuspended in an equal volume of MRS-THIO containing 0.2% sodium taurocholate and cholesterol. The cholesterollowering effect was assessed using the method described above.
Deconjugation of bile acid by LAB After preculture, all strains were harvested, washed with sterile water, and resuspended in sterile water as indicated above (to OD 650 of 0.15 at 1:10). The cells were diluted to 1:100 in MRS-THIO containing 0.2% sodium taurocholate and then incubated at 37℃ for 20 h, with shaking at 50 rpm. For each strain, 20 mL of the inoculated culture was adjusted to pH 7.0 by adding 1.0 N NaOH, and the total volume was brought to 25 mL with distilled water. The cells were harvested by centrifugation at 3,000 × g for 10 min at 4℃. An aliquot (15 mL) of the supernatant was transferred to a fresh tube, the pH was adjusted to 1.0 with 10 N HCl, and the total volume was adjusted to 24 mL with distilled water. For each sample, a 3 mL aliquot was transferred to a glass-stoppered test tube to which 9 mL ethyl acetate was added, followed by 1 mL of 1% furfuraldehyde. After mixing, the samples were heated at 65℃ for 13 min and then cooled to room temperature. Acetic acid (5 mL) was added to each tube and mixed, and optical density was subsequently read at 660 nm and compared with a standard curve to determine the concentration of free cholic acid. Results were expressed as micromoles of cholic acid per milliliter. Fresh (uninoculated) medium was used as the negative control.
After incubation, sodium taurocholate in the supernatant was analyzed using HPLC (D-7000, Hitachi, Ltd., Tokyo, Japan) with a C18 column (ϕ 4.6 × 350 mm) under the following conditions: solvent, 0.25 M K 2 HPO 4 /ethanol/methanol (50:40:10); flow rate, 0.6 mL/ min; UV detection, 210 nm.
Fluorescence detection of cholesterol Cellular incorporation of cholesterol was measured using the Cell-Based Detection Assay Kit (Cayman Chemical Company, MI, USA). L. brevis 119-2 was incubated in MRS-THIO containing 0.2% taurocholate and cholesterol. After incubation, the cells were washed with distilled water and then fixed in 4.0% formaldehyde for 10 min. The cells were then washed with the kit's washing buffer three times for 5 min each. Filipin III solution was added to the cells and the mixture was incubated in the dark for 30-60 minutes. The cells were washed with wash buffer two times for 5 min. Staining was observed using a fluorescent microscope at an excitation of 340-380 nm and emission of 387-470nm (BX51; Olympus Corporation, Tokyo, Japan).
Tolerance of L. brevis to artificial digestive fluid Bacterial tolerance to artificial digestive fluid was assayed using the modified method of Lee et al. (2008) . All the strains were determine the mechanism of the observed cholesterollowering effects (Table 1) , five strains, L. brevis 119-2, L. brevis NBRC3960, L. brevis NBRC13109, L. plantarum NRIC1918, and L. acidophilus ATCC43121, were examined. The cholesterol-lowering effects of autoclaved cells of these five strains were compared with those of viable cells. Because dead cells cannot perform any biological process, such as cellular cholesterol incorporation or cholesterol metabolism into other products, the cholesterol-lowering effect of the dead cells arises from their association with L. brevis. Fig. 1 Values for the heated and viable cells were 1.8 − 3.5 μg/mg dry cell weight and 17.4 − 20.2 μg/mg dry cell weight, respectively, demonstrating that the cholesterol-lowering effect of L. brevis requires live cells. Klaver et al. (1993) reported that cholesterol removal by L. acidophilus is not due to bacterial uptake of cholesterol, but results from bacterial bile salt-deconjugating activity. Therefore, we initially examined the deconjugation activity of five strains, to determine the mechanism of the cholesterol lowering effect in these strains. Fig. 2 shows the result of sodium taurocholate deconjugation by the six strains showing cholesterol-lowering effects. While sodium taurocholate levels in the growth medium of L. brevis 119-2, L. brevis NBRC1360, and L. brevis NBRC13109 decreased during growth, the decreases were not significant; cholic acid concentrations in the spent medium of these strains remained at trace levels. In contrast, sodium taurocholate was depleted to low (trace) levels in the spent medium of L. plantarum NRIC1918 and L. acidophilus ATCC43121, whereas cholic acid accumulated, to levels similar to the initial concentration of sodium taurocholate, in these cultures. Fig. 3 shows time-dependent changes in the growth me- (A) Tolerance to low pH was assessed as time-dependent changes in viable cell counts. pH 2.0 (△); pH 2.5 (•); pH 3.0 (○). The lower limit of detection was 10 3 cfu/ mL. (B) Tolerance to bile acid was assessed as time-dependent changes in OD 650 for growth medium of L. rhamnosus GG (■), L. brevis 119-6 (□), L. brevis 119-2 (■). Values are presented as mean ± standard deviation of three experiments per strain. One or two asterisks above each bar indicate significant differences (P < 0.02, P < 0.01 respectively) vs. control, and are normalized to the value of the control without Oxgall. served only in L. brevis 119-2, which exhibited a cholesterollowering effect (Fig. 4 (a) ).
The effect of artificial digestive fluid and adherence to Caco-2 cells Tolerance to simulated gastric juices and bile acid was evaluated in L. brevis 119-2 and L. brevis 119-6. L. rhamnosus GG was used as a control. As shown in Fig. 5 (a) , exposure to artificial gastric juice at pH 2.5 and pH 3.0 had no significant effect on the viability of L. brevis 119-2 and L. rhamnosus GG. Similarly, exposure to pH 3.0 did not impede L. brevis 119-6 viability. However, at pH 2.5 this strain gradually lost viability, with cell counts falling below 10 5 cfu/ mL by 4 h. For all the tested strains, exposure to artificial gastric Cholesterol in the growth medium gradually decreased from 100 % to 82.1 % during the initial 9 h, and further decreased to 25.1 % at 27 h. At the same time, cellular cholesterol incorporation levels gradually increased from trace to 8.2 % at 9 h and to 64.8 % at 27 h. Cholesterol levels in the precipitate gradually increased to reach 8.5 % at 27 h. The total cholesterol content in the medium, cell and precipitate of each sample was maintained at the same level as the initial cholesterol level of the medium. Fig. 4 (a) and ( Binding to the cell wall alone (by autoclaved killed cells) accounted for only one-eighth of the cholesterol-lowering effects of viable LAB (Fig. 1) . This result suggests that the cell viability had a positive effect. Notably, with respect to the deconjugation of sodium taurocholate, L. plantarum and L. acidophilus completely converted sodium taurocholate to cholic acid; such conversion was not seen with either of the L. brevis strains evaluated. This suggests that L. brevis does not have the ability to deconjugate bile salts.
To understand the behavior of cholesterol during culture, we determined cholesterol levels, over a 27 h time course, during anaerobic incubation of L. brevis 119-2 at 37℃. Cholesterol levels in the medium were decreased approximately 70% after 24 h incubation, with a complementary increase in cell-associated cholesterol levels over the same interval. Cholesterol levels in the cell fraction tended to correlate with OD 650 . Precipitation of cholesterol during 24 − 27 h was detected at approximately 10%, because it was thought that a portion of the cholesterol in the medium precipitated together with the presence of excess bacteria, and adhered to the surface of the culture vessel. The conservation of total cholesterol in every sampling fraction revealed that L. brevis 119-2 did not metabolize cholesterol (Fig. 3) . Furthermore we confirmed the apparent incorporation of cholesterol into L. brevis 119-2 by bacterial staining with fluorescent cholesterol detection reagents, which bind specifically to cholesterol (Fig. 4) . These results, and that shown in Fig. 1 , suggest that intact cholesterol was positively treated by viable cells, i.e., cholesterol was incorporated into the cell and did not bind to the cell wall alone. L. brevis 119-6, which did not exhibit any cholesterol-lowering effects, served as a reference that, as expected, was not stained (although slight auto-fluorescence was observed).
These results suggest that the mechanism of the cholesterol-lowering effect of L. brevis is the positive incorporation of cholesterol into bacterial cells. Indeed, Kimoto et al. (1999) reported that bacterial cell membranes incorporated cholesterol, changing the profile of membrane fatty acids. Noh et al. (1997) reported that L. acidophilus, which showed cholesterol incorporation, demonstrated increased resistance to lysis by sonication; however, the role of cholesterol incorporation by L. brevis remains unclear and will require further research. Kurdi et al. (2000) reported that many Lactobacilli accumulate cholic acid in their cells. We presumed that incorporated cholesterol was accumulated in the cells as well, because the cholesterol concentration was maintained during incubation.
However, L. brevis-mediated cholesterol uptake may be significant from the perspective of human health. To serve as a probiotic (particularly in the inhibition of intestinal juice at pH 2.0 killed the cells within 2 h. Fig. 5 (b) shows the effect of exposure to bile fluid. Growth of L. brevis 119-2 was promoted in a bile acid concentration-dependent manner, while the growth of L. rhamnosus GG and L. brevis 119-6 was inhibited by increasing concentrations of bile acids. Notably, the bile tolerance of both L. brevis strains was higher than that of the control strain. Fig. 6 shows the results of the adherence assay for L. brevis 119-2 and L. brevis 119-6 to intestinal epithelial Caco-2 cells. Lc. lactis NBRC12007 and L. rhamnosus GG served as negative and positive controls, respectively. As observed by crystal violet staining (Fig. 6 (A) ), L. brevis 119-2, L. brevis 119-6, and L. rhamnosus GG cells adhered to the Caco-2 cell surface; however, Lc. lactis NBRC12007 adherence was not observed. Fig. 6 (B) shows the number of viable cells adhering to Caco-2 cells. This assay revealed that bacterial adherence to epithelial cells was similar for L. brevis 119-2, L. brevis 119-6, and L. rhamnosus GG (18 − 23 cfu/ Caco-2 cell); these values were significantly higher than that observed for Lc. lactis.
Discussion
To identify potential prophylactics for metabolic syndrome, we isolated GABA-producing LAB from whole turnip and pickled turnip. We identified these LAB as L. brevis and designated the strains as L. brevis 119-2 and L. brevis 119-6, respectively. We showed the cholesterol-lowering effect of L. brevis in vitro for the first time and demonstrated that this effect resulted from L. brevis 119-2 cellular incorporation of cholesterol from the medium. We further demonstrated that L. brevis 119-2 and 119-6 exhibit potential probiotic properties, including resistance to simulated gastric fluids and/or adherence to epithelial cells in vitro.
Notably, the LAB strains L. brevis 119-2, L. brevis NBRC3960, L. brevis NBRC13109, and L. plantarum NRIC1918 were able to reduce cholesterol levels in the growth medium. The activity of these strains was significantly greater than that of any other strain and was straindependent (Table 1 ). The cholesterol-lowering effects of LAB have been attributed to several mechanisms, including coprecipitation with free bile acid by deconjugation of bile salts (Klaver et al., 1993) , incorporation of cholesterol micelles into the bacterial cell membrane at pH 6.0 (Noh et al., 1997) , conversion of cholesterol to coprostanol (Lye et al., 2010) , binding by cells (Hosono et al., 1995) , and LAB cell free supernatant-mediated effects (Kim et al., 2008) . To identify mechanism(s) of the cholesterol-lowering effect of L. brevis, we evaluated L. brevis 119-2 and L. brevis 119-6 for cholesterol binding to the cell wall, deconjugation of bile acid, and incorporation of cholesterol into the cell wall.
